Cancer: Bone Tumors (Osteosarcoma and Ewing Sarcoma)
Consortium: Harmonization International Bone Sarcoma Consortium (HIBiSCus)
Headquarters: University of Chicago
Consortium Manager: Kat Bouzein, kblumhardt@bsd.uchicago.edu
The Harmonization International Bone Sarcoma Consortium (HIBiSCus) was formally established in 2021. The HIBiSCus group includes experts in both osteosarcoma and Ewing sarcoma, as well as data contributions from Children’s Oncology Group (COG), Cooperative Ewing Sarcoma Study Group (CESS), Cooperative Osteosarcoma Study Group (COSS), Euro Ewing Consortium (EEC), French Bone Sarcoma Group (GROUPOS), Grupo America Latina de Oncologia Pediatrica (GALOP), Italian Study Group (ISG), National Cancer Research Institute Sarcoma Clinical Studies Group (NCRI), Scandinavian Sarcoma Group (SSG), and Spanish Sarcoma Group (GEIS). To date, HIBiSCus has identified data from over 7,500 Ewing sarcoma patients and over 5,000 osteosarcoma patients to be included in the data commons.